Kaleida Health/Diabetes Center

Buffalo, New York 14209

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Cerebrovascular Accident, Coronary Disease, Diabetes Mellitus, Type II, Heart Diseases, Myocardial Infarction, Type 2 Diabetes Mellitus

Studies at this site

• A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus — Completed
• Niacin Plus Statin to Prevent Vascular Events — Stopped early
• A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator — Completed